Dyne Therapeutics (DYN) PT Lowered to $36 at Morgan Stanley
Tweet
Share
E-mailGet Alerts DYN Hot Sheet
Price: $18.07 -1.9%
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Morgan Stanley analyst Michael E Ulz lowered the price target on Dyne Therapeutics (NASDAQ: DYN) to $36.00 (from $45.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Dyne Therapeutics (DYN) PT Lowered to $30 at RBC Capital Following NVS Setback
- Oracle (ORCL) PT Lowered to $200 at Stifel, Buy Rating Maintained
- Linde (LIN) PT Lowered to $563 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
